|| AstraZeneca vaccine 79% effective against symptomatic Covid ||AstraZeneca vaccine 79% effective against symptomatic Covid
Day: March 22, 2021
CNN3: ‘”}, “chartbeat”:{“sections”:””}, “branding_content_page”:”default”, “branding_content_zone”:[“default”, “branding_content_container”:”default”, “cnn-money-markets”, “space-and-science”, “branding_content_card”:””} , edition: “domestic” , sourceId: “‘]BANNER=|pagerendered| ((lubuntu at wor3 2J1P))
|| Experts are split over whether US is headed for another surge ||”},”chartbeat”:{“sections”:””},”branding_content_page”:”default”,”branding_content_zone”:[“default”],”branding_content_container”:[“default”,”cnn-money-markets”,”space-and-science”],”branding_content_card”:[“”]} , edition: “domestic” , sourceId: ”
CNN2: subjectpartBANNER=|=”banner-text screaming-banner-text banner-text-size–char-47″ data-analytics=”_list-hierarchical-xs_article_”>AstraZeneca vaccine 79% effective against symptomatic Covid| ((lubuntu at wor3 2J1P)))
nprnews_____ = ||| lubuntu at wor3 89S7|||AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||Results of the trial, which involved more than 32, 000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.
class=”imagewrap has-source-dimensions”
data-crop-type=”wide”
style=”
–source-width: 4101;
–source-height: 2306;
”
>

Results from a Phase III trial show the Oxford AstraZeneca COVID-19 vaccine can be 79% effective at preventing symptoms of COVID-19.
Finnbarr Webster/Getty Images
hide caption
toggle caption
Finnbarr Webster/Getty Images
The Coronavirus Crisis
AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says
European Scientists Zero In On AstraZeneca Blood Clot Link
CNN3: ‘”}, “chartbeat”:{“sections”:””}, “branding_content_page”:”default”, “branding_content_zone”:[“default”, “branding_content_container”:”default”, “cnn-money-markets”, “space-and-science”, “branding_content_card”:””} , edition: “domestic” , sourceId: “‘]BANNER=|pagerendered| ((lubuntu at wor3 89S7))
|| Experts are split over whether US is headed for another surge ||”},”chartbeat”:{“sections”:””},”branding_content_page”:”default”,”branding_content_zone”:[“default”],”branding_content_container”:[“default”,”cnn-money-markets”,”space-and-science”],”branding_content_card”:[“”]} , edition: “domestic” , sourceId: ”
CNN2: subjectpartBANNER=|=”banner-text screaming-banner-text banner-text-size–char-47″ data-analytics=”_list-hierarchical-xs_article_”>Experts are split over whether US is headed for another surge| ((lubuntu at wor3 89S7)))
CNN1: FOXVCNN=|Experts are split over whether US is headed for another surge| ((lubuntu at wor3 2J1P))
CNN3: ‘”}, “chartbeat”:{“sections”:””}, “branding_content_page”:”default”, “branding_content_zone”:[“default”, “branding_content_container”:”default”, “cnn-money-markets”, “space-and-science”, “branding_content_card”:””} , edition: “domestic” , sourceId: “‘]BANNER=|pagerendered| ((lubuntu at wor3 2J1P))
|| Why travelers and spring break crowds have US health experts worried ||”},”chartbeat”:{“sections”:””},”branding_content_page”:”default”,”branding_content_zone”:[“default”],”branding_content_container”:[“default”,”cnn-money-markets”,”space-and-science”],”branding_content_card”:[“”]} , edition: “domestic” , sourceId: ”








